US Patent 11285190 CLEC11a is a bone growth agent
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Rui Yue0
Sean Morrison0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112851900
Date of Patent
March 29, 2022
0Patent Application Number
155677620
Date Filed
April 18, 2016
0Official Website
Patent Primary Examiner
CPC Code
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Mar, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+304 characters)
US Patent 11285190 CLEC11a is a bone growth agent
Article
The present disclosure describes the C-type lectin CLEC11a as a bone growth factor. Clec11a-deficient mice showed reduced bone volume and mineralization, while bone resorption remained unchanged. Administration of recombinant Clec11a systemically promoted bone formation in mice at risk for osteoporosis.
Infobox
Is a
Patent jurisdiction
Patent number
11285190
Date of patent
March 29, 2022
Patent application number
15567762
Date Filed
April 18, 2016
Patent primary examiner
Find more entities like US Patent 11285190 CLEC11a is a bone growth agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.